Cytomegalovirus colitis in a CMV-seropositive renal transplant recipient on triple drug therapy (including mycophenolate).
Smak Gregoor
P J
PJ
Department of Internal Medicine I, University Hospital Rotterdam-Dijkzigt, The Netherlands.
van Gelder
T
T
Abraham Tanis
A
A
Chadha-Ajwani
S
S
Klaassen
R J
RJ
Weimar
W
W
D003092:Colitis / Q000473:pathology / Q000821:virology*; D003106:Colon / Q000473:pathology; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000175:diagnosis*; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D011182:Postoperative Care; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D012698:Serologic Tests
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid; D011241:Prednisone